We are live on ! Find out more
NDRA icon

ENDRA Life Sciences
NDRA

8 hedge funds and large institutions have $507K invested in ENDRA Life Sciences in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0% → 0% (+0%)

20% less funds holding

Funds holding: 10 → 8 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

53% less capital invested

Capital invested by funds: $1.08M → $507K (-$578K)

Holders
8
Holders Change
-2
Holders Change %
-20%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$75.4K
2
JP Morgan Chase
JP Morgan Chase
New York
+$25.1K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$8.38K
4
UBS Group
UBS Group
Switzerland
+$8.38K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$8.38K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$86K
2
State Street
State Street
Massachusetts
-$32K
3
Citadel Advisors
Citadel Advisors
Florida
-$23K
4
Northern Trust
Northern Trust
Illinois
-$19K
5
TRCT
Tower Research Capital (TRC)
New York
-$8.38K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$203K +$8.38K +1 +4%
Morgan Stanley
2
Morgan Stanley
New York
$176K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$78K +$8.38K +1 +10%
Osaic Holdings
4
Osaic Holdings
Arizona
$18K – – –
JP Morgan Chase
5
JP Morgan Chase
New York
$18K +$25.1K +3 New
UBS Group
6
UBS Group
Switzerland
$8.75K +$8.38K +1 New
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
$3K – – –
WAM
8
Worth Asset Management
Texas
$1.1K – – –
BlackRock
9
BlackRock
New York
$415 – – –
NA
10
NewEdge Advisors
Louisiana
$134 – – –
Wells Fargo
11
Wells Fargo
California
$90 – – –
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$63 +$75.4K +9 New
Bank of America
13
Bank of America
North Carolina
$24 – – –
Renaissance Technologies
14
Renaissance Technologies
New York
– -$86K -8 Closed
State Street
15
State Street
Massachusetts
– -$32K -3 Closed
Citadel Advisors
16
Citadel Advisors
Florida
– -$23K -2 Closed
Northern Trust
17
Northern Trust
Illinois
– -$19K -2 Closed
TRCT
18
Tower Research Capital (TRC)
New York
– -$8.38K -1 Closed
IC
19
IEQ Capital
California
– -$5K – –
National Bank of Canada
20
National Bank of Canada
Quebec, Canada
– -$1K – –

NDRA Hedge Fund Activity: Q4 2022 in Review

8 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q4 2022, worth a combined $507K — down 53% from $1.08M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of NDRA and 3 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Dimensional Fund Advisors, opening a new position worth an estimated $75.4K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $86K sold.

  • 8 institutional investors held ENDRA Life Sciences (NDRA) as of Q4 2022, down from 10 in Q3 2022.
  • Funds reported $507K of ENDRA Life Sciences stock for Q4 2022, down 53% quarter-over-quarter.
  • 3 funds opened new ENDRA Life Sciences positions in Q4 2022 and 5 closed out, a net change of -2 holders.
  • The largest ENDRA Life Sciences buyer in Q4 2022 was Dimensional Fund Advisors, an estimated $75.4K added.
  • The largest ENDRA Life Sciences seller in Q4 2022 was Renaissance Technologies, an estimated $86K sold.

Based on aggregated 13F filings for Q4 2022.